Activity space during treatment with medication for opioid use disorder: Relationships with personality, mood, and drug use

被引:0
|
作者
Panlilio, Leigh, V [1 ]
Burgess-Hull, Albert J. [1 ]
Feldman, Jeffrey D. [1 ]
Rogers, Jeffrey M. [1 ,2 ]
Tyburski, Matthew [1 ]
Smith, Kirsten E. [1 ]
Epstein, David H. [1 ]
机构
[1] NIDA, Intramural Res Program NIDA IRP, Real World Assessment Predict & Treatment RAPT Uni, 251 Bayview Blvd, Baltimore, MD 21224 USA
[2] SDSU UCSD Joint Doctoral Program in Clin Psychol, 6363 Alvarado Ct, San Diego, CA 92120 USA
关键词
Activity space; GPS; Addiction; Opioid use disorder; Cocaine use; NEIGHBORHOOD; BEHAVIOR; EXPOSURE; INEQUALITIES; STABILITY; MOBILITY; FEATURES; COCAINE; TOOL;
D O I
10.1016/j.josat.2023.209219
中图分类号
B849 [应用心理学];
学科分类号
040203 ;
摘要
Introduction: Activity space in people with substance use disorders (SUDs) has been assessed for theoretical reasons and for detection/prevention of relapse. In this observational study, we relate passively obtained activity space measures to mental states and behaviors relevant to the success of treatment for opioid use disorder. Our long-term goal is to use such data to assess risk in real time and to recognize when SUD patients might benefit from a just-in-time intervention.Methods: We used GPS data from 238 urban residents in the first 16 weeks of stabilization on medication for opioid use disorder to test preregistered hypotheses about activity space (distance traveled, number of locations, time spent moving, and psychosocial-hazard levels of neighborhoods where participants spent time) in relation to certain static variables (personality, mood propensities) and time-varying treatment-relevant behaviors such as craving and use of opioids and cocaine.Results: The most consistent findings were that 1) mobility decreased over the course of the study; 2) neuroticism was associated with overall lower mobility; 3) trait-like positive mood (averaged from momentary ratings) was associated with higher mobility; 4) participants who used cocaine more frequently had lower mobility; 5) early in treatment, participants spent less time moving (i.e., were more sedentary) on days when they were craving. Some of these findings were in the expected direction (i.e., the ones involving neuroticism and positive mood), and some were opposite to the expected direction (i.e., we expected cocaine use to be associated with higher mobility); others (e.g., changes in mobility over time or in relation to craving) involved nondirectional hypotheses.Conclusions: Real-time information that patients actively provide is valuable for assessing their current state, but providing this information can be burdensome. The current results indicate that certain static or passively obtained data (personality variables and GPS-derived mobility information) are relevant to time-varying, treatment-relevant mental states and drug-related behavior, and therefore might be useful when incorporated into algorithms for detecting need for intervention in real time. Further research should assess how population-specific these relationships are, and how these passive measures can best be combined with low temporal -density, actively-provided data to obtain valid, reliable assessments with minimal burden.
引用
收藏
页数:10
相关论文
共 50 条
  • [1] Medication Treatment of Opioid Use Disorder
    Bell, James
    Strang, John
    [J]. BIOLOGICAL PSYCHIATRY, 2020, 87 (01) : 82 - 88
  • [2] Medication Treatments for Opioid Use Disorder: What Is the Impact on Mood and Mood Disorders?
    Hassan A.N.
    Nunes E.
    [J]. Current Addiction Reports, 2018, 5 (3) : 303 - 311
  • [3] Polysubstance use before and during treatment with medication for opioid use disorder: Prevalence and association with treatment outcomes
    Bunting, Amanda M.
    Krawczyk, Noa
    Choo, Tse-Hwei
    Pavlicova, Martina
    McNeely, Jennifer
    Tofighi, Babak
    Rotrosen, John
    Nunes, Edward
    Lee, Joshua D.
    [J]. JOURNAL OF SUBSTANCE ABUSE TREATMENT, 2022, 143
  • [4] Medication for the Treatment of Opioid Use Disorder in Pregnancy Is Essential
    Poland, Cara
    Stoltman, Jonathan J. K.
    Felton, Julia W.
    [J]. JAMA INTERNAL MEDICINE, 2024, 184 (03) : 254 - 255
  • [5] Medication-assisted treatment for opioid use disorder
    Kaplan, Louise
    [J]. NURSE PRACTITIONER, 2019, 44 (03): : 10 - 12
  • [6] Enacted Stigma From Family and Drug Use During Opioid Use Disorder Treatment
    Earnshaw, Valerie A.
    Brousseau, Natalie M.
    Hill, E. Carly
    Laurenceau, Jean-Philippe
    Sepucha, Karen R.
    Qiu, Xueli
    Mousavi, Mohammad
    Morrison, Lynn M.
    Kelly, John F.
    [J]. STIGMA AND HEALTH, 2024,
  • [7] Medication-Based Treatment to Address Opioid Use Disorder
    Leshner, Alan I.
    Dzau, Victor J.
    [J]. JAMA-JOURNAL OF THE AMERICAN MEDICAL ASSOCIATION, 2019, 321 (21): : 2071 - 2072
  • [8] Medication-Assisted Treatment for Opioid-Use Disorder
    Oesterle, Tyler S.
    Thusius, Nuna J.
    Rummans, Teresa A.
    Gold, Mark S.
    [J]. MAYO CLINIC PROCEEDINGS, 2019, 94 (10) : 2072 - 2086
  • [9] Association of Medication Treatment for Opioid Use Disorder With Suicide Mortality
    Watts, Bradley, V
    Gottlieb, Daniel J.
    Riblet, Natalie B.
    Gui, Jiang
    Shiner, Brian
    [J]. AMERICAN JOURNAL OF PSYCHIATRY, 2022, 179 (04): : 298 - 304
  • [10] Medication Treatment of Active Opioid Use Disorder in Veterans With Cirrhosis
    Rogal, Shari
    Youk, Ada
    Agbalajobi, Olufunso
    Zhang, Hongwei
    Gellad, Walid
    Fine, Michael J.
    Belperio, Pamela
    Morgan, Timothy
    Good, Chester B.
    Kraemer, Kevin
    [J]. AMERICAN JOURNAL OF GASTROENTEROLOGY, 2021, 116 (07): : 1406 - 1413